Arcus Capital Partners, LLC I Bio, Inc. Transaction History

Arcus Capital Partners, LLC

  • $255 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 28, 2022
SELL
$0.55 - $1.04 $24,107 - $45,585
-43,832 Closed
0 $0
Q4 2020

Feb 11, 2021
BUY
$1.05 - $2.24 $46,023 - $98,183
43,832 New
43,832 $46,000

About iBio, Inc.

IBIO Quotes by TradingView
  • Ticker IBIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,006,580
  • Market Cap $24M
  • Description
  • iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...
More about IBIO
Track This Portfolio

Track Arcus Capital Partners, LLC Portfolio

Follow Arcus Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arcus Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arcus Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email